Search research articles
Contact Us
Filters
Showing results (101-110 of 109) with videos related to
Page
of 11
Sort By:
You have reached the last page of results.
This site can display upto 109 results.
Nature Medicine
|
January 25, 2012
cGMP-Prkg1 signaling and Pde5 inhibition shelter cochlear hair cells and hearing function
Mirko Jaumann, Juliane Dettling, Martin Gubelt, et al.
JCI Insight
|
February 7, 2023
CYB5R3 in type II alveolar epithelial cells protects against lung fibrosis by suppressing TGF-β1 signaling
Marta Bueno, Jazmin Calyeca, Timur Khaliullin, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society
|
August 22, 2021
Riociguat for the treatment of Phe508del homozygous adults with cystic fibrosis
Nico Derichs, Jennifer L Taylor-Cousar, Jane C Davies, et al.
Journal of Medicinal Chemistry
|
May 31, 2017
Discovery of the Soluble Guanylate Cyclase Stimulator Vericiguat (BAY 1021189) for the Treatment of Chronic Heart Failure
Markus Follmann, Jens Ackerstaff, Gorden Redlich, et al.
American Journal of Respiratory Cell and Molecular Biology
|
December 22, 2017
Nitric Oxide-Independent Soluble Guanylate Cyclase Activation Improves Vascular Function and Cardiac Remodeling in Sickle Cell Disease
Karin P Potoka, Katherine C Wood, Jeffrey J Baust, et al.
Journal of Medicinal Chemistry
|
April 19, 2021
Discovery of the Soluble Guanylate Cyclase Activator Runcaciguat (BAY 1101042)
Michael G Hahn, Thomas Lampe, Sherif El Sheikh, et al.
Journal of Medicinal Chemistry
|
April 11, 2023
New Generation of sGC Stimulators: Discovery of Imidazo[1,2-<i>a</i>]pyridine Carboxamide BAY 1165747 (BAY-747), a Long-Acting Soluble Guanylate Cyclase Stimulator for the Treatment of Resistant Hypertension
Alexandros Vakalopoulos, Frank Wunder, Ingo V Hartung, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|
August 12, 2025
Soluble guanylate cyclase stimulation improves cardiac function and mitochondrial activity in a rat model of early-stage heart failure with preserved ejection fraction
Xocas Vázquez-Abuín, Sandra Moraña-Fernández, Alana Aragón-Herrera, et al.
Rheumatology (Oxford, England)
|
March 9, 2024
Biomarker analysis from the phase 2b randomized placebo-controlled trial of riociguat in early diffuse cutaneous systemic sclerosis
Dinesh Khanna, Frank Kramer, Josef Höfler, et al.
Page
of 11
Search research articles
Search
Showing results (101-110 of 109) with videos related to
Sort By:
Page
of 11
You have reached the last page of results.
This site can display upto 109 results.
Nature Medicine
|
January 25, 2012
cGMP-Prkg1 signaling and Pde5 inhibition shelter cochlear hair cells and hearing function
Mirko Jaumann, Juliane Dettling, Martin Gubelt, et al.
JCI Insight
|
February 7, 2023
CYB5R3 in type II alveolar epithelial cells protects against lung fibrosis by suppressing TGF-β1 signaling
Marta Bueno, Jazmin Calyeca, Timur Khaliullin, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society
|
August 22, 2021
Riociguat for the treatment of Phe508del homozygous adults with cystic fibrosis
Nico Derichs, Jennifer L Taylor-Cousar, Jane C Davies, et al.
Journal of Medicinal Chemistry
|
May 31, 2017
Discovery of the Soluble Guanylate Cyclase Stimulator Vericiguat (BAY 1021189) for the Treatment of Chronic Heart Failure
Markus Follmann, Jens Ackerstaff, Gorden Redlich, et al.
American Journal of Respiratory Cell and Molecular Biology
|
December 22, 2017
Nitric Oxide-Independent Soluble Guanylate Cyclase Activation Improves Vascular Function and Cardiac Remodeling in Sickle Cell Disease
Karin P Potoka, Katherine C Wood, Jeffrey J Baust, et al.
Journal of Medicinal Chemistry
|
April 19, 2021
Discovery of the Soluble Guanylate Cyclase Activator Runcaciguat (BAY 1101042)
Michael G Hahn, Thomas Lampe, Sherif El Sheikh, et al.
Journal of Medicinal Chemistry
|
April 11, 2023
New Generation of sGC Stimulators: Discovery of Imidazo[1,2-<i>a</i>]pyridine Carboxamide BAY 1165747 (BAY-747), a Long-Acting Soluble Guanylate Cyclase Stimulator for the Treatment of Resistant Hypertension
Alexandros Vakalopoulos, Frank Wunder, Ingo V Hartung, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|
August 12, 2025
Soluble guanylate cyclase stimulation improves cardiac function and mitochondrial activity in a rat model of early-stage heart failure with preserved ejection fraction
Xocas Vázquez-Abuín, Sandra Moraña-Fernández, Alana Aragón-Herrera, et al.
Rheumatology (Oxford, England)
|
March 9, 2024
Biomarker analysis from the phase 2b randomized placebo-controlled trial of riociguat in early diffuse cutaneous systemic sclerosis
Dinesh Khanna, Frank Kramer, Josef Höfler, et al.
Page
of 11